Penicillamine-D 50 mg/mL in SyrSpend SF pH4 Oral Suspension

A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

LEARN MORE

Penicillamine-D 50 mg/mL in SyrSpend SF pH4 Oral Suspension

Author(s): Allen Loyd V Jr

Issue: Jan/Feb 2018 - Volume 22, Number 1
View All Articles in Issue

Page(s): 55

Penicillamine-D 50 mg/mL in SyrSpend SF pH4 Oral Suspension Page 1

Download in electronic PDF format for $65

Abstract: A formulation for preparing Penicillamine-D 50 mg/mL in SyrSpend SF pH4 Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, formulation, penicillamine-D, chelating agent, heavy metals, rheumatoid arthritis, cystinuria, primary biliary cirrhosis, scleroderma, Wilson disease, copper poisoning, lead poisoning

Related Categories: EXCIPIENTS, FORMULATIONS, GASTROENTEROLOGY, ALLERGY/IMMUNOLOGY/INFLAMMATION

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Penicillamine-D 50 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Jan/Feb 2018 Pg. 55
Wetting and/or Solubilizing Agents, Featured Excipient: Allen Loyd V Jr	Jul/Aug 2001 Pg. 310-312
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
Effectiveness in Oral Rhus toxicodendron Solution for Poison Ivy Prevention Stein Michael F, Parsons Eric	Jul/Aug 2003 Pg. 272-275
Basics: Excipients Used in Nonsterile Compounding, Part 4: Antioxidants and Chelating Agents Allen Loyd V Jr	Jan/Feb 2020 Pg. 38-43
Treating Canine Hepatic Disease Davidson Gigi S	May/Jun 2003 Pg. 188-191
The Treatment of Canine Atopic Disease Davidson Gigi S	May/Jun 2002 Pg. 210-215
Stability of Atenolol, Clonazepam, Dexamethasone, Diclofenac Sodium, Diltiazem, Enalapril Maleate, Ketoprofen, Lamotrigine, Penicillamine-D, and Thiamine in SyrSpend SF PH4 Oral Suspensions Polonini HC, Loures S, Lima LC, Ferreira AO, Brandão MA	Mar/Apr 2016 Pg. 167-174
Basics of Compounding for Raynaud's Disease Glasnapp Andrew	Jul/Aug 2003 Pg. 288-291
Ursodiol 30 mg/mL in SyrSpend SF Cherry Oral Suspension Allen Loyd V Jr	Nov/Dec 2019 Pg. 493

Particle Measuring Systems - USP <797> Environmental Monitoring Solutions